Skip to main content

Series D Pharmaceutical Companies

Explore 9 pharmaceutical startups that raised series d funding. Access verified founder contact information and fundraising data.

Total Companies
9
Total Funding
$570.7M
Avg Funding
$63.4M
Cities
9

Export 9 Series D Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
New York, United States

Click Therapeutics develops and commercializes software as prescription medical treatments designed to address unmet healthcare needs.

Apr 2026
Series D

Founder Contacts

19,000+ verified contacts

San Francisco, United States
$19.8M
raised

Numerion Labs develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

Mar 2026
Series D

Founder Contacts

19,000+ verified contacts

Boulder, United States
$150.0M
raised

Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.

Sep 2025
Series D

Founder Contacts

19,000+ verified contacts

Seattle, United States
$100.0M
raised

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Jul 2025
Series D

Founder Contacts

19,000+ verified contacts

Aliso Viejo, United States
$75.0M
raised

Spyglass Pharma provides medicine for ophthalmic diseases.

Jun 2025
Series D

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 9 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Ann Arbor, United States
$65.0M
raised

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

Sep 2024
Series D

Founder Contacts

19,000+ verified contacts

Zurich, Switzerland
$59.0M
raised

SkyCell focuses on developing temperature controlled logistics containers for the pharmaceutical industry.

Jun 2024
Series D

Founder Contacts

19,000+ verified contacts

Montreal, Canada
$80.0M
raised

DalCor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits

Sep 2023
Series D

Founder Contacts

19,000+ verified contacts

Seongnam, South Korea
$21.9M
raised

1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients.

Jan 2026
Series D

Founder Contacts

19,000+ verified contacts

Ready to Connect with Series D Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 9 series d pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked